for the Period Ended 30 June 2024
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes |
for the Period Ended
2024 | ||
---|---|---|
| £ | |
Turnover: | | |
Cost of sales: | ( | |
Gross profit(or loss): | | |
Distribution costs: | ( | |
Administrative expenses: | ( | |
Other operating income: | | |
Operating profit(or loss): | ( | |
Interest receivable and similar income: | | |
Interest payable and similar charges: | | |
Profit(or loss) before tax: | ( | |
Tax: | | |
Profit(or loss) for the financial year: | ( |
As at
Notes | 2024 | ||
---|---|---|---|
| £ | ||
Called up share capital not paid: | | ||
Fixed assets | |||
Intangible assets: | 3 | | |
Tangible assets: | 4 | | |
Investments: | 5 | | |
Total fixed assets: | | ||
Current assets | |||
Stocks: | 6 | | |
Debtors: | 7 | | |
Cash at bank and in hand: | | ||
Investments: | 8 | | |
Total current assets: | | ||
Prepayments and accrued income: | | ||
Creditors: amounts falling due within one year: | 9 | ( | |
Net current assets (liabilities): | | ||
Total assets less current liabilities: | | ||
Creditors: amounts falling due after more than one year: | 10 | ( | |
Provision for liabilities: | ( | ||
Accruals and deferred income: | ( | ||
Total net assets (liabilities): | | ||
Capital and reserves | |||
Called up share capital: | | ||
Share premium account: | | ||
Other reserves: | | ||
Profit and loss account: | | ||
Total Shareholders' funds: | |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 June 2024
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Intangible fixed assets amortisation policy
Valuation information and policy
for the Period Ended 30 June 2024
2024 | ||
---|---|---|
Average number of employees during the period | |
for the Period Ended 30 June 2024
Goodwill | Other | Total | |
---|---|---|---|
Cost | £ | £ | £ |
Additions | | | |
Disposals | | | |
Revaluations | | | |
Transfers | | | |
At 30 June 2024 | | | |
Amortisation | |||
Charge for year | | | |
On disposals | | | |
Other adjustments | | | |
At 30 June 2024 | | | |
Net book value | |||
At 30 June 2024 | | |
for the Period Ended 30 June 2024
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
Additions | | | | | | |
Disposals | ||||||
Revaluations | ||||||
Transfers | ||||||
At 30 June 2024 | | | | | | |
Depreciation | ||||||
Charge for year | ||||||
On disposals | ||||||
Other adjustments | ||||||
At 30 June 2024 | ||||||
Net book value | ||||||
At 30 June 2024 | | | | | |
for the Period Ended 30 June 2024
New Horizon Health and Medicare's fixed assets investments include investment projects, investments in subsidiaries, equity investments, and loans to subsidiaries.Investment projects are valued at fair value, with a total of £2,350,000 as of 2023, reflecting additions and revaluation gains during the year.Investments in Subsidiaries: Carried at costless impairment, totalling £5,500,000 in 2023, with additional investments made during the year.Equity Investments: Classified as FVOCI and measured at fair value, totalling £1,175,000 in 2023, with increases from both new additions and changes in fair value.Loans to Subsidiaries: Measured at amortized cost, totaling £1,550,000 in 2023, including new loans advanced and accrued interest.The total value of fixed asset investments as of 2023 is £10,575,000, reflecting the company's ongoing investment and growth strategy.
for the Period Ended 30 June 2024
2024 | ||
---|---|---|
£ | ||
Stocks | | |
Total | |
for the Period Ended 30 June 2024
2024 | ||
---|---|---|
£ | ||
Trade debtors | | |
Prepayments and accrued income | | |
Total | |
for the Period Ended 30 June 2024
New Horizon Health and Medicare's current assets investments comprise the following:Short-Term Investments: £750,000, representing investments in marketable securities and other financial instruments with maturities of less than one year.Trade Receivables: £1,500,000, consisting of amounts owed by clients and customers for services rendered, less any allowances for doubtful accounts.Other Receivables: £300,000, including advances, accrued income, and other receivables not classified under trade receivables.Cash and Cash Equivalents: £1,200,000, comprising cash on hand, bank balances, and short-term deposits.The total value of current assets investments stands at £1010000.00 for the fiscal year, reflecting an increase in liquidity and investment in short-term assets.
for the Period Ended 30 June 2024
2024 | ||
---|---|---|
£ | ||
Bank loans and overdrafts | | |
Amounts due under finance leases and hire purchase contracts | | |
Other creditors | | |
Total | |
for the Period Ended 30 June 2024
2024 | ||
---|---|---|
£ | ||
Bank loans and overdrafts | | |
Amounts due under finance leases and hire purchase contracts | | |
Other creditors | | |
Total | |
for the Period Ended 30 June 2024